Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic …

Cancer cachexia characterized by a chronic wasting syndrome, involves skeletal muscle
loss and adipose tissue loss and resistance to conventional nutritional support. Cachexia is …

It is estimated that half of all patients with cancer eventually develop a syndrome of
cachexia, with anorexia and a progressive loss of adipose tissue and skeletal muscle mass …

Cancer-related fatigue (CRF) is one of the most prevalent symptoms patients with cancer
experience, both during and after treatment. CRF is pervasive and affects patients' quality of …

Many forms of cancer present with a complex metabolic profile characterised by loss of lean
body mass known as cancer cachexia. The physical impact of cachexia contributes to …

The Apc Min/+ mouse has a mutation in the Apc tumor suppressor gene and develops
intestinal polyps, beginning at 4 wk of age. This mouse develops cachexia by 6 mo …

A common challenge for scientists working with animal tissue or human biopsy samples is
the limitation of material and consequently, the difficulty to perform comprehensive metabolic …

Cancer patients often experience weight loss caused by protein calorie malnutrition (PCM)
during the course of the disease or treatment. PCM is expressed as severe if the patient has …

Background Physical function is an independent predictor of numerous chronic diseases,
but its association with all-cause mortality in older adults diagnosed with cancer has …

Cancer cachexia is a multifactorial syndrome that develops during malignant tumor growth.
Changes in plasma levels of several hormones and inflammatory factors result in an intense …